Patent Assignment
Reel/Frame 057496/0726
Assignment of Assignor's Interest
Recorded: 2021-09-16
Pages: 3
Assignor
CATALENT PHARMA SOLUTIONS, LLC
Executed: 2021-09-14
Assignee
SAGE THERAPEUTICS, INC.
215 FIRST STREET, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(2)
Formulations of 19-nor C3,3- Disubstituted C21-N-Pyrazolyl Steroid and Methods of Use Thereof
PCT:
PCT/US2021/042394 ↗
Formulations of 19-nor C3,3-Disubstituted C21-N-Pyrazolyl Steroid and Methods of Use Thereof
Application:
63/054,070 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 16, 2021
From: WATSON, PAUL STEVEN; BERNER, BRET; NARAYAN, PADMA; CHEN, XIAOXIA
To: SAGE THERAPEUTICS, INC.
Reel/Frame 056563/0483 →
Assignment of Assignor's Interest
Sep 16, 2021
From: STUTZMAN, TODD ANTHONY; MENG, JIANING; WILKERSON, CAROLYN S.; RAMNIK JAIN, RAJ
To: CATALENT PHARMA SOLUTIONS, LLC
Reel/Frame 057496/0665 →
Assignment of Assignor's Interest
Jul 24, 2024
From: WATSON, PAUL STEVEN; BERNER, BRET; NARAYAN, PADMA; CHEN, XIAOXIA
To: SAGE THERAPEUTICS, INC.
Reel/Frame 068067/0519 →